Dishman Carbogen Amcis Limited (DCAL) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Dishman Carbogen Amcis Limited (DCAL) has a cash flow conversion efficiency ratio of 0.046x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Rs2.95 Billion ≈ $31.93 Million USD) by net assets (Rs63.65 Billion ≈ $688.35 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Dishman Carbogen Amcis Limited (DCAL) defensive interval to measure how many days the company can operate on defensive assets alone.
Dishman Carbogen Amcis Limited - Cash Flow Conversion Efficiency Trend (2005–2025)
This chart illustrates how Dishman Carbogen Amcis Limited's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Dishman Carbogen Amcis Limited Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Dishman Carbogen Amcis Limited ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Zen Voce
TWO:3581
|
-0.017x |
|
Zhubo Design
SHE:300564
|
-0.027x |
|
Bravo Mining Corp
V:BRVO
|
-0.005x |
|
Nongshim Holdi
KO:072710
|
0.015x |
|
Orbit Technologies Ltd
TA:ORBI
|
-0.056x |
|
Chengdu Shengbang Seals Co.Ltd.
SHE:301233
|
0.020x |
|
Sangam (India) Limited
NSE:SANGAMIND
|
0.009x |
|
Fujian Nanwang Environment Protection Scien-Tech Co. Ltd. A
SHE:301355
|
N/A |
Annual Cash Flow Conversion Efficiency for Dishman Carbogen Amcis Limited (2005–2025)
The table below shows the annual cash flow conversion efficiency of Dishman Carbogen Amcis Limited from 2005 to 2025. For the full company profile with market capitalisation and key ratios, see Dishman Carbogen Amcis Limited stock valuation.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-03-31 | Rs58.32 Billion ≈ $630.66 Million |
Rs3.75 Billion ≈ $40.58 Million |
0.064x | -5.70% |
| 2024-03-31 | Rs56.27 Billion ≈ $608.59 Million |
Rs3.84 Billion ≈ $41.52 Million |
0.068x | +49.05% |
| 2023-03-31 | Rs58.10 Billion ≈ $628.29 Million |
Rs2.66 Billion ≈ $28.76 Million |
0.046x | -28.42% |
| 2022-03-31 | Rs55.49 Billion ≈ $600.10 Million |
Rs3.55 Billion ≈ $38.38 Million |
0.064x | -28.91% |
| 2021-03-31 | Rs56.99 Billion ≈ $616.31 Million |
Rs5.13 Billion ≈ $55.44 Million |
0.090x | -12.14% |
| 2020-03-31 | Rs57.15 Billion ≈ $618.06 Million |
Rs5.85 Billion ≈ $63.28 Million |
0.102x | +95.28% |
| 2019-03-31 | Rs53.79 Billion ≈ $581.73 Million |
Rs2.82 Billion ≈ $30.50 Million |
0.052x | +18.26% |
| 2018-03-31 | Rs51.07 Billion ≈ $552.34 Million |
Rs2.26 Billion ≈ $24.49 Million |
0.044x | -29.48% |
| 2017-03-31 | Rs48.14 Billion ≈ $520.61 Million |
Rs3.03 Billion ≈ $32.73 Million |
0.063x | -67.24% |
| 2016-03-31 | Rs14.52 Billion ≈ $157.03 Million |
Rs2.79 Billion ≈ $30.13 Million |
0.192x | -16.61% |
| 2015-03-31 | Rs12.42 Billion ≈ $134.30 Million |
Rs2.86 Billion ≈ $30.91 Million |
0.230x | -19.70% |
| 2014-03-31 | Rs12.02 Billion ≈ $130.01 Million |
Rs3.45 Billion ≈ $37.26 Million |
0.287x | +120.10% |
| 2013-03-31 | Rs10.55 Billion ≈ $114.06 Million |
Rs1.37 Billion ≈ $14.85 Million |
0.130x | -21.25% |
| 2012-03-31 | Rs9.29 Billion ≈ $100.45 Million |
Rs1.54 Billion ≈ $16.61 Million |
0.165x | -28.31% |
| 2011-03-31 | Rs8.79 Billion ≈ $95.08 Million |
Rs2.03 Billion ≈ $21.93 Million |
0.231x | -40.14% |
| 2010-03-31 | Rs7.84 Billion ≈ $84.81 Million |
Rs3.02 Billion ≈ $32.68 Million |
0.385x | +105.98% |
| 2009-03-31 | Rs7.04 Billion ≈ $76.18 Million |
Rs1.32 Billion ≈ $14.25 Million |
0.187x | +120.69% |
| 2008-03-31 | Rs5.73 Billion ≈ $62.02 Million |
Rs486.09 Million ≈ $5.26 Million |
0.085x | -36.93% |
| 2007-03-31 | Rs3.18 Billion ≈ $34.39 Million |
Rs427.32 Million ≈ $4.62 Million |
0.134x | +64.50% |
| 2006-03-31 | Rs1.89 Billion ≈ $20.39 Million |
Rs154.02 Million ≈ $1.67 Million |
0.082x | +151.73% |
| 2005-03-31 | Rs1.47 Billion ≈ $15.91 Million |
Rs-232.28 Million ≈ $-2.51 Million |
-0.158x | -- |
About Dishman Carbogen Amcis Limited
Dishman Carbogen Amcis Limited provides contract research and manufacturing services for the pharmaceutical and healthcare industries worldwide. The company operates through Contract Research and Manufacturing Services and Marketable Molecules segments. It offers cholesterol and vitamin D analogs; generic active pharmaceutical ingredients for diagnostics, ophthalmic treatments, laxatives, organop… Read more